The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTrakm8 Hldgs Regulatory News (TRAK)

Share Price Information for Trakm8 Hldgs (TRAK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 9.25
Bid: 8.50
Ask: 10.00
Change: 0.00 (0.00%)
Spread: 1.50 (17.647%)
Open: 9.25
High: 9.25
Low: 9.25
Prev. Close: 9.25
TRAK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

AGM Statement & Trading Update

21 Sep 2023 07:00

RNS Number : 0843N
Trakm8 Holdings PLC
21 September 2023
 

 

21 September 2023

Trakm8 Holdings plc

('Trakm8' or the 'Group')

 

AGM Statement & Trading Update

 

John Watkins, Executive Chairman of Trakm8 Holdings plc (AIM: TRAK), the global telematics and data insight provider, will make the following statement on current trading at Trakm8's Annual General meeting ("AGM") being held today.

 

"The financial year has started in line with management's expectations, details of which were set out in the Company's announcement on 4 July 2023. Pleasingly, Fleet and Optimisation revenues have been ahead of last year. However, as anticipated, Insurance revenues continue to be supressed because of the capacity constraints in the Insurance market which have persisted, though the addition of two new customers recently has provided some mitigation to this. Notwithstanding this, a very large increase in the cost of insurance policies has significantly impacted the insurance market.

 

During the first five months of the current financial year, new unit sales have decreased by 28% to 63,402 (last year's corresponding period: 87,362). With the renewal of insurance policies also impacted, total connections have reduced overall by approximately 6% to 326,000.

 

The Group has benefitted from the considerably lower levels of overheads following the cost reduction actions taken by the Board last year. We expect revenues for the six months ending 30 September 2023 to be slightly lower than last year's, but with a significantly lower cost base delivering a significantly improved result.

 

We have recently undertaken a capital investment amounting to £0.5m in our in-house data centres and as a result expect to significantly reduce the external cost of hosting our platforms. The investment and overhead reductions are anticipated to be fully operational by the start of the second half of this financial year. This capital investment is anticipated to save £0.6m per annum.

 

We had originally expected that during the second half of the current financial year the capacity issues would reduce. However, we now believe that the downside risk of these challenges may continue for the remainder of the financial year. We expect a third new client with capacity to start ordering within the next few weeks. As a result, we expect that the number of connections at year end (31 March 2024) will increase by circa 7% to 350,000, which will be the driver for increased recurring revenues in subsequent years.

 

As previously advised, our expectations for the financial year remain dependent on both the recovery of the capacity in the Insurance market and ongoing discussions regarding securing a further significant new software contract which we hope will be achieved at the end of the current financial year. We remain confident in our current profit expectations for this financial year; however this will be achieved on lower revenues due to the insurance capacity and pricing issues offset by the lower cost base."

 

- Ends -

 

 

 

For further information:

Trakm8 Holdings plc

 

John Watkins, Executive Chairman

Tel: +44 (0) 1675 434 200

Jon Edwards, Chief Financial Officer

www.trakm8.com

 

 

 

Allenby Capital Limited (Nominated Adviser & Broker)

Tel: +44 (0)20 3328 5656

David Hart / Vivek Bhardwaj, Corporate FinanceTony Quirke / Joscelin Pinnington, Sales and Corporate Broking 

 

www.allenbycapital.com

 

About Trakm8

 

Trakm8 is a UK based technology leader in fleet management, insurance telematics, connected car, and optimisation. Through IP owned technology, the Group uses AI data analytics collected from its installed base of telematics units to fine tune the algorithms that are used to produce its' solutions; these monitor driver behaviour, identify crash events and monitor vehicle health to provide actionable insights to continuously improve the security and operational efficiency of both company fleets and private drivers.

The Group's product portfolio includes the latest data analytics and reporting portal (Trakm8 Insight), integrated telematics/cameras/optimisation, self-installed telematics units and one of the widest ranges of installed telematics devices. Trakm8 has over 326,000 connections.

Headquartered in Coleshill near Birmingham alongside its manufacturing facility, the Group supplies to the Fleet, Optimisation, Insurance and Automotive sectors to many well-known customers in the UK and internationally including the AA, Saint Gobain, EON, Iceland Foods, GSF, Direct Line Group, Ticker and Howden Driving Data.

Trakm8 has been listed on the AIM market of the London Stock Exchange since 2005. Trakm8 is also recognised with the LSE Green Economy Mark.

 

www.trakm8.com / @Trakm8

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
AGMLMMLTMTTTMIJ
Date   Source Headline
3rd Apr 20247:00 amRNSTrading Update, Contract Extension & CLNs Issue
22nd Mar 20247:00 amRNSTrading update
24th Nov 20237:00 amRNSHalf-year Report
15th Nov 20239:37 amRNSDirectorate Change
7th Nov 20239:46 amRNSHolding(s) in Company
21st Sep 202311:13 amRNSResult of Annual General Meeting (AGM)
21st Sep 20237:00 amRNSAGM Statement & Trading Update
25th Aug 20237:00 amRNSNotice of AGM and Capital Markets Day
7th Jul 202311:18 amRNSAward of options
4th Jul 20237:00 amRNSFinal Results
25th Apr 20237:00 amRNSYear End Trading Update
20th Apr 20237:00 amRNSContract Award
30th Mar 20237:00 amRNSIceland Foods Awards Contract Extension
29th Mar 20237:00 amRNSSainsbury’s Awards Optimisation Contract Extension
28th Mar 20237:00 amRNSContract Award
22nd Feb 20237:00 amRNSCapital Markets Day
15th Dec 20228:05 amRNSAward of Options
8th Dec 20227:00 amRNSHalf Year Results
28th Nov 202211:58 amRNSDirector Dealing
22nd Sep 202210:46 amRNSResult of Annual General Meeting (AGM)
22nd Sep 20227:00 amRNSAGM Statement & Trading Update
14th Sep 20228:00 amRNSTrading and Strategy Update and Issue of CLN
18th Aug 20227:00 amRNSNotice of AGM
22nd Jul 20227:00 amRNSCompletion of Nominated Adviser due diligence
6th Jul 20227:00 amRNSContract Award
29th Jun 20227:00 amRNSFinal Results
27th Apr 20222:00 pmRNSChange of Nominated Adviser and Broker
26th Apr 20227:00 amRNSTrading Update
29th Mar 20227:00 amRNSContract Extension
22nd Mar 20227:00 amRNSContract Award
18th Mar 20227:00 amRNSContract Extension
2nd Dec 20217:00 amRNSContract Award
19th Nov 20213:57 pmRNSAward of Options
16th Nov 20217:00 amRNSHalf Year Results and Director Change
1st Oct 20217:00 amRNSAppointment of Director
27th Sep 20217:00 amRNSAward of Green Economy Mark
23rd Sep 202111:00 amRNSResult of Annual General Meeting (AGM)
23rd Sep 20217:00 amRNSAGM Statement & Trading Update
19th Aug 20212:33 pmRNSNotice of Annual General Meeting
13th Jul 20217:00 amRNSAward of options
12th Jul 20217:00 amRNSDirectorate Change
29th Jun 20217:00 amRNSFinal Results
22nd Jun 20217:00 amRNSNotice of Results
28th Apr 20217:00 amRNSYear End Trading Update
12th Mar 20217:00 amRNSDirector Dealings
25th Feb 20217:00 amRNSContract Award and Trading Update
30th Nov 20207:00 amRNSIssue of Options
23rd Nov 20207:00 amRNSHalf-Year Results
17th Sep 202010:00 amRNSResult of AGM
17th Sep 20207:00 amRNSChairman's Statement

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.